All Work

Jon C. Ogg

6 Analyst Stock Picks With Massive Upside Targets

This last week may have been short and light on investing interest in the United States. After all, millions of passengers flying out or driving out on Wednesday, then eating more turkey than can…

Jon C. Ogg · 11 years ago

Durable Goods Look Quite Durable for October

Each report on Durable Goods feels like a bit of a wild card. After all, things like cars and planes and a whole host of other big-ticket capital goods are very volatile during good…

Jon C. Ogg · 11 years ago

Positive Revision for Third Quarter GDP

The United States got some good news for the economic yardstick measurement for growth. Gross Domestic Product (GDP) was revised higher for the third quarter. The Department of Commerce and Bureau of Economic Analysis…

Jon C. Ogg · 11 years ago

Analysts Start MyoKardia With Positive Ratings

MyoKardia, Inc. (NASDAQ: MYOK) has now moved far enough beyond the October 28 IPO pricing that the analysts in the underwriting syndicate can now begin their awaited analyst coverage. The end of the quiet…

Jon C. Ogg · 11 years ago

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Teva Pharmaceutical Industries Limited (NYSE: TEVA) had a very hard time getting off the ground from 2011 through the start of 2014. This is the world’s top generic drug maker, and shares have gained…

Jon C. Ogg · 11 years ago